Septic shock in children. Is it different than adults? Peter Kanizsai, MD, PhD associate professor in emergency medicine

Similar documents
Printed copies of this document may not be up to date, obtain the most recent version from

The Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya

Staging Sepsis for the Emergency Department: Physician

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Printed copies of this document may not be up to date, obtain the most recent version from

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

Use of surrogate inflammatory markers in the diagnosis & monitoring of patients with severe sepsis

Current State of Pediatric Sepsis. Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018

Sepsis Management: Past, Present, and Future

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

5/1/2015 SEPSIS SURVIVING SEPSIS CAMPAIGN HOW TO APPROACH THE POSSIBLE SEPTIC CHILD 2015 INFECTION CAN BE CONFIRMED BY:

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign

Initial Resuscitation of Sepsis & Septic Shock

SEPSIS UPDATE WHY DO WE NEED A CORE MEASURE CHAD M. KOVALA DO, FACOEP, FACEP

SEPSIS BIOMARKERS. Dr.Saad Baher ElBadawi

SEPSIS SYNDROME

Date written: April 2014 Review date: April 2016 Related documents: Paediatric Sepsis 6

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

Updates in Emergency Department Management of Sepsis

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Sepsis: Identification and Management in an Acute Care Setting

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Fluorescence immunoassay Point of care test Wide range PCT. whole blood. plasma. serum

Procalcitonin kinetics guided antibiotic management of the critically ill patient

Pediatric Septic Shock. Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee

Sepsis: Management ANUPOL PANITCHOTE, MD. Division of Critical Care Medicine Department of Medicine, Khon Kaen University, Thailand

Updates in Sepsis 2017

Pediatric Sepsis Treatment:

ADVANCES IN BIOMARKER TESTING FOR SEPSIS AND BACTERIAL INFECTIONS

towards early goal directed therapy

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Pediatric emergencies (SHOCK & COMA) Dr Mubarak Abdelrahman Assistant Professor Jazan University

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

Understand the scope of sepsis morbidity and mortality Identify risk factors that predispose a patient to development of sepsis Define and know the

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

Evidence- Based Medicine Fluid Therapy

Early Goal-Directed Therapy

Surviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview

Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway

Sepsis Awareness and Education

Nothing to disclose 9/25/2017

9/25/2017. Nothing to disclose

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Organ Donor Management Recommended Guidelines ADULT CARDIAC DEATH (DCD)

Disclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice

Managing Patients with Sepsis

Adsorbtion of Cytokines Early in Septic Shock: the ACESS trial

Immunomodulation and Sepsis in Oncological Patients. Imad Haddad, M.D. Medical Director, PICU Banner Children s Hospital at BDMC

BREAK 11:10-11:

Shock and hemodynamic monitorization. Nilüfer Yalındağ Öztürk Marmara University Pendik Research and Training Hospital

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

Advancements in Sepsis

Key Points. Angus DC: Crit Care Med 29:1303, 2001

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Sepsis. From EMS to ER to ICU. What we need to be doing

BIOMARKERS IN SEPSIS

The changing face of

Episode 50 Pediatric Sepsis With Dr. Sarah Reid & Dr. Gina Neto. Pediatric Sepsis

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Sepsis and Shock States

John Park, MD Assistant Professor of Medicine

EARLY GOAL DIRECTED THERAPY : seminaires iris. Etat des lieux en Daniel De Backer

Dilemmas in Septic Shock

Basics from anatomy and physiology classes Local tissue reactions

SURVIVING SEPSIS: Early Management Saves Lives

SEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.

Paediatric Shock. Dr Andrew Pittaway Department of Anaesthesia Bristol Royal Hospital for Children Bristol, UK

Controversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy

MAKING SENSE OF IT ALL AUGUST 17

SEPSIS: Seeing Through the. W. Graham Carlos MD, MSCR, ATSF, FACP

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

Identification & Treatment of Sepsis for the Pediatric Population

Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018

Core Measures SEPSIS UPDATES

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Diagnosis: Allergies:

Management of Severe Sepsis:

SEPSIS & SEPTIC SHOCK

New Strategies in the Management of Patients with Severe Sepsis

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

FLUID MANAGEMENT AND BLOOD COMPONENT THERAPY

PCT-assisted antibiotic therapy

PCT-assisted antibiotic therapy

Sepsi: nuove definizioni, approccio diagnostico e terapia

Frank Sebat, MD - June 29, 2006

Organ Donor Management Recommended Guidelines ADULT Brain Death (NDD)

4/4/2014. Of patients diagnosed with sepsis 50% will develop severe sepsis 25% will develop shock. SIRS Sepsis Severe Septic Sepsis Shock.

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN

Sepsis! Dr Eric Van Den Bergh Consultant in Emergency Medicine 2015

What is sepsis? RECOGNITION. Sepsis I Know It When I See It 9/21/2017

Brief summary of the NICE guidelines December 2013

Surviving Sepsis Campaign

Sepsis Wave II Webinar Series. Sepsis Reassessment

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire

Sepsis Management Update 2014

6/29/2017. Role of Biomarkers in the Management of Heart Failure Patients. What s New in Biomarkers for HF Patients?

Transcription:

Septic shock in children. Is it different than adults? Peter Kanizsai, MD, PhD associate professor in emergency medicine

http://www.ipaustralia.com.au/applicant/clinical-excellence-commission/trademarks/1473265/ Vincent et al: Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit The Lancet Respiratory Medicine Volume 2, Issue 5, May 2014, Pages 380 386

EARLY RECOGNITION EARLY EVALUATION EARLY STABILIZATION

But how?.. http://radiopaedia.org/play/2031/case/12221/studies/12534 http://pl.wikipedia.org/wiki/sepsa

2013.

qsofa AMS with recent onset Respiratory rate > 22/min Systolic BP <100 Hgmm S E P S I S

0-5 minutes Signs of poor perfusion Decreased (altered) mental status Cold extremities Delayed CRT Weak pulses, differential central and peripheral pulses Low urine output (if measured) Hypotension or low BP age dependent Assess ABCs Provide 100% oxygen at high flow rate (15L) Early intubation in neonates and infants Respiratory support, including mechanical ventilation Establish IV access and start monitoring 2 large-bore peripheral IVs or IOs Blood sampling: blood gas, lactate, glucose, ionized calcium, FBC, cultures http://emedicine.medscape.com/article/2072410-overview

5-15 minutes Fluid and electrolyte resuscitation Push 20 ml/kgcrystalloid IV/IO over 5-20min Repeat 20 ml/kg bolus push of fluid (up to 60 ml/kg) until clinical symptoms improve or patient develops respiratory distress/rales/ hepatomegaly May continue to require additional fluid above 60 ml/kg (fluid refractory) Fluid needs may approach 200 ml/kg in warm septic shock (warm extremities, flash capillary refill) Correct hypoglycemia: Glucose levels in hypoglycemia Glucose dosage: 0.5-1 g/kg IV/IO Correct hypocalcemia for low ionized calcium: Calcium gluconate 100 mg/kg IV/IO (max 2g) PRN Calcium chloride 20 mg/kg IV/IO PRN http://emedicine.medscape.com/article/2072410-overview

5-60 minutes Infection control (5-60min) Immediate considerations: Administer antibiotics immediately after cultures obtained (blood, urine, +/- CSF/ sputum) Do not delay antibiotics to wait for cultures; initial antibiotics should be given within 1h General treatment recommendations: Empiric therapy should be used for unknown etiology of sepsis; Tailoring of therapy to address suspected pathogens or to achieve adequate drug penetration may be necessary; Broader initial coverage may be needed for initial stabilization Dosing varies by age and weight (see specific recommendations and dosages immediately below) Duration of therapy: Determined by ultimate source of infection; 7-10d is typically sufficient Above regimens may be empiric therapy for 48-72h, until cultures and sensitivities are known, so as to accurately tailor treatment If culture-negative sepsis, antibiotic choice and duration determined by severity of presentation and most likely pathogen Infectious disease consultation may be necessary http://emedicine.medscape.com/article/2072410-overview

15-60 minutes Fluid-refractory shock (persisting after 60 ml/kg fluid) CVP, vasopressors Shock persists following vasopressor initiation Fluid, CVP, ScvO 2 Fluid refractory and vasopressor-dependent shock Hydrocortisone 2 mg/kg Continued shock PiCCO, ECMO http://emedicine.medscape.com/article/2072410-overview

Supplemental treatment Blood transfusion considered for Hb < 100 g/l (ideal threshold for transfusion unknown) Optimize oxygenation through ventilation IV immunoglobulin can be considered (?) http://emedicine.medscape.com/article/2072410-overview

Therapeutic endpoints Heart rate normalized for age Capillary refill < 2sec Normal pulse quality No difference in central and peripheral pulses Warm extremities Blood pressure normal for age Urine output >1 ml/kg/h Normal mental status CVP >8 mmhg http://emedicine.medscape.com/article/2072410-overview

1. Deliver high-flow oxygen. 2. Take blood cultures. 3. Administer empiric intravenous antibiotics. 4. Measure serum lactate and send full blood count. 5. Start intravenous fluid resuscitation. 6. Commence accurate urine output measurement.

Antibiotics : remedies with controversy and confusion Problems with delay Δ 7,6 %/ hour Kumar A, et al. Crit Care Med 2006; 34: 1589-96

Antibiotics: remedies with controversy and confusion Problems with resistance Increased rate of fungal infections after 7 days. Increased polyresistance after 10 days. Marchetti O et al. Clin Infect Dis 2004;38:311-320 Albrich W, et al. Emerg Infect Dis 2004; 10: 514-517

Microorganisms resistant to almost every antibiotic are already present in the ICUs of many countries, requiring the use of old and toxic antibiotics such as colistin No new antibacterial agent active against Gram-negative bacteria is expected in the next 5 years The European Centre for Diseases Control estimate is that 25,000 patients in Europe might die from infections due to resistant organisms every year We engage ourselves to use antibiotics wisely, only when necessary, and to systematically re-evaluate therapy at day 2 or 3 of therapy. This last point is absolutely key for the success of the programme.

Antibiotics: remedies with controversy and confusion Problems with AB associated colitis Especially with amoxicillin, cephalosporins and clindamycin Incidence: 97 hospitals across 34 European countries, the incidence of C. diff in hospitalized patients was 41 per 100,000 patient-days 1 Treatment: metronidazol+vancomycin 1 Bauer MP et al: Lancet. 2011; 377(9759):63-73

Antibiotics : remedies with controversy and confusion Problems with cost

Why do we need PCT? https://www.aacc.org/publications/cln/2009/july/pages/series0709.aspx

Innate inflammatory response: cell stress, insult, damage, bacteria PCT leucocyte, lymphocyte, endothel, parenchymal cells TLR4, CD14, MD2, mannos-mbl, NOD, NALP, P substance Humoral adaptive response Cascade activation coagulation, complement cytokines Acute phase proteins Stress hormones Hormokines Cytoplasmatic factors immun- regulation IFN- Il-2 IL-4 IL-5 IL-7 IL-11 MIF IL-1β IL-6 IL-8 IL-12 IL-11 IL-18 NO PGs TNF- proinflammatory adhesion molec. kemokines elastáse endhotelin growth fact. IL-1 decoy LTs protease ROI TBs antiinflammatory IL-4 IL-6 IL-10 IL-11 IL-13 IL-ra Leptin NO TNF TGF-β 1-glicoprot. ferritin fibronectin haptoglobin LPS prot. SAA CRP ACTH AVP GH cortisol prolactin histamin NA, Adr. endorphin ADM CGRP PCT IL-6 leptin MIF From J. Fazakas with permission HS protein HMG-1 NO

Kinetics of procalcitonin Brunkhorst F.M. et al., Intens Care Med 1998,24: 888-892

Why better than CRP? Kinetics. http://www.procalcitonin.com/default.aspx?tree=_2_2

Why better than CRP? Risk stratification. http://www.procalcitonin.com/default.aspx?tree=_2_2

Why better than CRP? Therapy guidance. http://www.procalcitonin.com/default.aspx?tree=_2_2

Thorough literature search PCT and CAP etiology PCT and disease severity PCT and AB administrarion PCT vs other markers

Eur J Emerg Med. 2014 Apr;21(2):112-7. doi: 10.1097/MEJ.0b013e328361fee2. Procalcitonin as a biomarker for early sepsis in the emergency department. Hicks CW, Engineer RS, Benoit JL, Dasarathy S, Christenson RH, Peacock WF. proadrenomedullin (MRproADM) midregional proatrial natriuretic peptide (MRproANP) procalcitonin (PCT)* Copeptin proendothelin-1 (proet-1) *median 0.32 ng/ml (IQR 0.19-1.17) vs. 0.18 ng/ml (IQR 0.07-0.54); P=0.04

Multimarker approach Key messages: More than 170 different biomarkers have been assessed for potential use in sepsis, more for prognosis than for diagnosis. None has sufficient specificity or sensitivity to be routinely employed in clinical practice (on its own). Combinations of several biomarkers may be more effective than single biomarkers, but this requires further evaluation.

Thank you for your attention!